RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,057 filers reported holding RAYTHEON CO in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $333,000 | -25.8% | 2,173 | 0.0% | 0.26% | -16.0% |
| Q3 2018 | $449,000 | +6.9% | 2,173 | 0.0% | 0.31% | +0.7% |
| Q2 2018 | $420,000 | -10.4% | 2,173 | 0.0% | 0.30% | -13.6% |
| Q1 2018 | $469,000 | +15.0% | 2,173 | 0.0% | 0.35% | +12.8% |
| Q4 2017 | $408,000 | +0.7% | 2,173 | 0.0% | 0.31% | -10.3% |
| Q3 2017 | $405,000 | +15.4% | 2,173 | 0.0% | 0.35% | +15.6% |
| Q2 2017 | $351,000 | +6.0% | 2,173 | 0.0% | 0.30% | -0.7% |
| Q1 2017 | $331,000 | +7.1% | 2,173 | 0.0% | 0.30% | 0.0% |
| Q4 2016 | $309,000 | +4.4% | 2,173 | 0.0% | 0.30% | +4.5% |
| Q3 2016 | $296,000 | +0.3% | 2,173 | 0.0% | 0.29% | -3.3% |
| Q2 2016 | $295,000 | +10.9% | 2,173 | 0.0% | 0.30% | +12.4% |
| Q1 2016 | $266,000 | -1.8% | 2,173 | 0.0% | 0.27% | -6.0% |
| Q4 2015 | $271,000 | +14.3% | 2,173 | 0.0% | 0.28% | +15.4% |
| Q3 2015 | $237,000 | +13.9% | 2,173 | 0.0% | 0.25% | +58.7% |
| Q2 2015 | $208,000 | -12.2% | 2,173 | 0.0% | 0.16% | -8.8% |
| Q1 2015 | $237,000 | +0.9% | 2,173 | 0.0% | 0.17% | +7.6% |
| Q4 2014 | $235,000 | +6.3% | 2,173 | 0.0% | 0.16% | +6.8% |
| Q3 2014 | $221,000 | +10.5% | 2,173 | 0.0% | 0.15% | +11.3% |
| Q2 2014 | $200,000 | -7.0% | 2,173 | 0.0% | 0.13% | -8.9% |
| Q1 2014 | $215,000 | – | 2,173 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |